Biogen Inc. buy Needham & Company LLC
Start price
28.06.24
/
50%
€212.90
Target price
28.06.25
€274.57
Performance (%)
-49.72%
End price
29.06.25
€107.05
Summary
This prediction ended on 29.06.25 with a price of €107.05. The BUY prediction by Needham___Company_LL for Biogen Inc. performed very badly with a performance of -49.72%. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 1.844% | 1.844% | 26.547% |
| iShares Core DAX® | -0,82 % | -2,03 % | 9,73 % |
| iShares Nasdaq 100 | -1,74 % | -5,35 % | -0,86 % |
| iShares Nikkei 225® | 1,21 % | 6,38 % | 27,79 % |
| iShares S&P 500 | -1,17 % | -3,46 % | 0,10 % |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $294.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten